Warnex Inc. Successfully Passes Inspection by European Health Authority

LAVAL, QUEBEC--(Marketwire - April 27, 2010) - Warnex Inc. (TSX: WNX) today reported that its Bioanalytical Services division successfully passed a Good Clinical Practices (GCP) inspection by the Austrian Agency for Health and Food Safety (AGES). The inspection was a routine, study-specific inspection of a bioequivalence study whose objective was to evaluate the organization’s adherence to the applicable regulatory requirements.

“This positive outcome demonstrates once again Warnex’s continued commitment to the highest level of quality in all of our laboratory operations,” said Mark Busgang, President and CEO of Warnex. “In addition to our successful inspections by the FDA in our Bioanalytical division, Warnex has now added a successful inspection by a European health authority, which we intend to leverage in our business development efforts in the European market.”

AGES (www.ages.at) is an Austrian government organization, composed of 18 federal institutes and departments with various areas of expertise, which is responsible for several tasks in regards to public health, including nutrition and the safety and effectiveness of medications. The organization researches, analyzes and performs inspections according to the policy guidelines of Austrian food laws and medication laws.

About Warnex

Warnex (www.warnex.ca) is a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical and healthcare sectors. Warnex Analytical Services provides pharmaceutical and biotechnology companies with a variety of quality control services, including chemistry, chromatography, microbiology, method development and validation, and stability studies. Warnex Bioanalytical Services specializes in bioequivalence and bioavailability studies for clinical trials. Warnex Medical Laboratories provides specialized testing for the healthcare industry as well as pharmaceutical and central laboratory services. Warnex PRO-DNA Services offers DNA identification tests for paternity, maternity and other family relationships, as well as for immigration and forensic testing purposes. Warnex has three facilities located in Laval and Blainville, Quebec, and Thunder Bay, Ontario.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this news release are forward-looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties, relating to financial resources, liquidity risk, key customers and business partners, credit risk, foreign currency risk, government regulations, laboratory facilities, volatility of share price, employees, suppliers, and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Warnex’s most recent Management’s Discussion and Analysis, which can be found at www.sedar.com. Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.